How much did Fagron achieve in EBIT for the current year?
In the current year, Fagron has achieved an EBIT of 129.37 M EUR.
Fagron EBIT 2024
Fagron EBIT
129.37 M EUR
Ticker
FAGR.BR
ISIN
BE0003874915
WKN
A0M103
In 2024, Fagron's EBIT was 129.37 M EUR, a 16.47% increase from the 111.08 M EUR EBIT recorded in the previous year.
The Fagron EBIT history
| YEAR | EBIT (undefined EUR) |
|---|---|
| 2029e | - |
| 2028e | 175.89 |
| 2027e | 165.78 |
| 2026e | 154.19 |
| 2025e | 141.1 |
| 2024e | 129.37 |
| 2023 | 111.08 |
| 2022 | 100.34 |
| 2021 | 89.21 |
| 2020 | 91.83 |
| 2019 | 87.44 |
| 2018 | 76 |
| 2017 | 75.95 |
| 2016 | 68.46 |
| 2015 | 77.1 |
| 2014 | 95.11 |
| 2013 | 72.9 |
| 2012 | 58.6 |
| 2011 | 45.9 |
| 2010 | 35.4 |
| 2009 | 30.5 |
| 2008 | 30 |
| 2007 | 28.8 |
| 2006 | 26.3 |
| 2005 | 29.8 |
| 2004 | 28.3 |
Fagron Revenue, EBIT, Net Income BE0003874915 · A0M103
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Fagron, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fagron from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fagron’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Fagron. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Fagron’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Fagron’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fagron’s growth potential.
Fagron Revenue, EBIT and net profit per share
| Date | Fagron Revenue | Fagron EBIT | Fagron Net Income |
|---|---|---|---|
| 2029e | 1.15 B EUR | 0 EUR | 0 EUR |
| 2028e | 1.08 B EUR | 175.89 M EUR | 0 EUR |
| 2027e | 1.03 B EUR | 165.78 M EUR | 115.84 M EUR |
| 2026e | 986.52 M EUR | 154.19 M EUR | 109.44 M EUR |
| 2025e | 923.99 M EUR | 141.1 M EUR | 96.53 M EUR |
| 2024e | 869.48 M EUR | 129.37 M EUR | 85.17 M EUR |
| 2023 | 762.99 M EUR | 111.08 M EUR | 70.55 M EUR |
| 2022 | 683.88 M EUR | 100.34 M EUR | 69.61 M EUR |
| 2021 | 573.81 M EUR | 89.21 M EUR | 61 M EUR |
| 2020 | 555.97 M EUR | 91.83 M EUR | 59.6 M EUR |
| 2019 | 534.7 M EUR | 87.44 M EUR | 41.06 M EUR |
| 2018 | 471.68 M EUR | 76 M EUR | 42.49 M EUR |
| 2017 | 433.53 M EUR | 75.95 M EUR | 46.66 M EUR |
| 2016 | 421.84 M EUR | 68.46 M EUR | -20.56 M EUR |
| 2015 | 427.56 M EUR | 77.1 M EUR | -202.33 M EUR |
| 2014 | 447.06 M EUR | 95.11 M EUR | 16.23 M EUR |
| 2013 | 386.1 M EUR | 72.9 M EUR | -32.1 M EUR |
| 2012 | 547 M EUR | 58.6 M EUR | 43.9 M EUR |
| 2011 | 493.6 M EUR | 45.9 M EUR | 28.1 M EUR |
| 2010 | 425.3 M EUR | 35.4 M EUR | 22.4 M EUR |
| 2009 | 393.6 M EUR | 30.5 M EUR | 19.6 M EUR |
| 2008 | 358.7 M EUR | 30 M EUR | 14.9 M EUR |
| 2007 | 308.2 M EUR | 28.8 M EUR | 16.3 M EUR |
| 2006 | 278.9 M EUR | 26.3 M EUR | 12.1 M EUR |
| 2005 | 286.1 M EUR | 29.8 M EUR | 15.1 M EUR |
| 2004 | 289.9 M EUR | 28.3 M EUR | 13.8 M EUR |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 289.9 M EUR | 28.3 M EUR | 13.8 M EUR |
| 2005 | 286.1 M EUR | 29.8 M EUR | 15.1 M EUR |
| 2006 | 278.9 M EUR | 26.3 M EUR | 12.1 M EUR |
| 2007 | 308.2 M EUR | 28.8 M EUR | 16.3 M EUR |
| 2008 | 358.7 M EUR | 30 M EUR | 14.9 M EUR |
| 2009 | 393.6 M EUR | 30.5 M EUR | 19.6 M EUR |
| 2010 | 425.3 M EUR | 35.4 M EUR | 22.4 M EUR |
| 2011 | 493.6 M EUR | 45.9 M EUR | 28.1 M EUR |
| 2012 | 547 M EUR | 58.6 M EUR | 43.9 M EUR |
| 2013 | 386.1 M EUR | 72.9 M EUR | -32.1 M EUR |
| 2014 | 447.06 M EUR | 95.11 M EUR | 16.23 M EUR |
| 2015 | 427.56 M EUR | 77.1 M EUR | -202.33 M EUR |
| 2016 | 421.84 M EUR | 68.46 M EUR | -20.56 M EUR |
| 2017 | 433.53 M EUR | 75.95 M EUR | 46.66 M EUR |
| 2018 | 471.68 M EUR | 76 M EUR | 42.49 M EUR |
| 2019 | 534.7 M EUR | 87.44 M EUR | 41.06 M EUR |
| 2020 | 555.97 M EUR | 91.83 M EUR | 59.6 M EUR |
| 2021 | 573.81 M EUR | 89.21 M EUR | 61 M EUR |
| 2022 | 683.88 M EUR | 100.34 M EUR | 69.61 M EUR |
| 2023 | 762.99 M EUR | 111.08 M EUR | 70.55 M EUR |
| 2024e | 869.48 M EUR | 129.37 M EUR | 85.17 M EUR |
| 2025e | 923.99 M EUR | 141.1 M EUR | 96.53 M EUR |
| 2026e | 986.52 M EUR | 154.19 M EUR | 109.44 M EUR |
| 2027e | 1.03 B EUR | 165.78 M EUR | 115.84 M EUR |
| 2028e | 1.08 B EUR | 175.89 M EUR | 0 EUR |
| 2029e | 1.15 B EUR | 0 EUR | 0 EUR |
Fagron stock margins BE0003874915 · A0M103
The Fagron margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fagron. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fagron.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Fagron's sales revenue. A higher gross margin percentage indicates that the Fagron retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Fagron's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Fagron's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fagron's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fagron. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fagron's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Fagron Margin History
| Fagron Gross margin | Fagron Profit margin | Fagron EBIT margin | Fagron Profit margin |
|---|---|---|---|
| 2029e | 43.59 % | 0 % | 0 % |
| 2028e | 43.59 % | 16.21 % | 0 % |
| 2027e | 43.59 % | 16.13 % | 11.27 % |
| 2026e | 43.59 % | 15.63 % | 11.09 % |
| 2025e | 43.59 % | 15.27 % | 10.45 % |
| 2024e | 43.59 % | 14.88 % | 9.8 % |
| 2023 | 43.59 % | 14.56 % | 9.25 % |
| 2022 | 41.84 % | 14.67 % | 10.18 % |
| 2021 | 43.13 % | 15.55 % | 10.63 % |
| 2020 | 44.38 % | 16.52 % | 10.72 % |
| 2019 | 44.89 % | 16.35 % | 7.68 % |
| 2018 | 44.16 % | 16.11 % | 9.01 % |
| 2017 | 43.68 % | 17.52 % | 10.76 % |
| 2016 | 43.72 % | 16.23 % | -4.87 % |
| 2015 | 44.84 % | 18.03 % | -47.32 % |
| 2014 | 47.45 % | 21.27 % | 3.63 % |
| 2013 | 44.31 % | 18.88 % | -8.31 % |
| 2012 | 34.42 % | 10.71 % | 8.03 % |
| 2011 | 33.93 % | 9.3 % | 5.69 % |
| 2010 | 32.89 % | 8.32 % | 5.27 % |
| 2009 | 32.06 % | 7.75 % | 4.98 % |
| 2008 | 31.98 % | 8.36 % | 4.15 % |
| 2007 | 33.03 % | 9.34 % | 5.29 % |
| 2006 | 33.27 % | 9.43 % | 4.34 % |
| 2005 | 32.19 % | 10.42 % | 5.28 % |
| 2004 | 31.46 % | 9.76 % | 4.76 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 31.46 % | 9.76 % | 4.76 % |
| 2005 | 32.19 % | 10.42 % | 5.28 % |
| 2006 | 33.27 % | 9.43 % | 4.34 % |
| 2007 | 33.03 % | 9.34 % | 5.29 % |
| 2008 | 31.98 % | 8.36 % | 4.15 % |
| 2009 | 32.06 % | 7.75 % | 4.98 % |
| 2010 | 32.89 % | 8.32 % | 5.27 % |
| 2011 | 33.93 % | 9.3 % | 5.69 % |
| 2012 | 34.42 % | 10.71 % | 8.03 % |
| 2013 | 44.31 % | 18.88 % | -8.31 % |
| 2014 | 47.45 % | 21.27 % | 3.63 % |
| 2015 | 44.84 % | 18.03 % | -47.32 % |
| 2016 | 43.72 % | 16.23 % | -4.87 % |
| 2017 | 43.68 % | 17.52 % | 10.76 % |
| 2018 | 44.16 % | 16.11 % | 9.01 % |
| 2019 | 44.89 % | 16.35 % | 7.68 % |
| 2020 | 44.38 % | 16.52 % | 10.72 % |
| 2021 | 43.13 % | 15.55 % | 10.63 % |
| 2022 | 41.84 % | 14.67 % | 10.18 % |
| 2023 | 43.59 % | 14.56 % | 9.25 % |
| 2024e | 43.59 % | 14.88 % | 9.8 % |
| 2025e | 43.59 % | 15.27 % | 10.45 % |
| 2026e | 43.59 % | 15.63 % | 11.09 % |
| 2027e | 43.59 % | 16.13 % | 11.27 % |
| 2028e | 43.59 % | 16.21 % | 0 % |
| 2029e | 43.59 % | 0 % | 0 % |
Fagron Aktienanalyse
What does Fagron do?
Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands. The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels. Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia. Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals. Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations). The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets. The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics. The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation. Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered. Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Fagron's EBIT
Fagron's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Fagron's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Fagron's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Fagron’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Fagron stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Fagron.
How has the EBIT of Fagron developed in recent years?
The EBIT of Fagron has increased by 16.468% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Fagron?
The EBIT of Fagron is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Fagron pay?
Over the past 12 months, Fagron paid a dividend of 0.25 EUR . This corresponds to a dividend yield of about 1.36 %. For the coming 12 months, Fagron is expected to pay a dividend of 0.28 EUR.
What is the dividend yield of Fagron?
The current dividend yield of Fagron is 1.36 %.
When does Fagron pay dividends?
Fagron pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Fagron?
Fagron paid dividends every year for the past 0 years.
What is the dividend of Fagron?
For the upcoming 12 months, dividends amounting to 0.28 EUR are expected. This corresponds to a dividend yield of 1.55 %.
In which sector is Fagron located?
Fagron is assigned to the 'Health' sector.
Wann musste ich die Aktien von Fagron kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Fagron from 5/23/2024 amounting to 0.3 EUR, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.
When did Fagron pay the last dividend?
The last dividend was paid out on 5/23/2024.
What was the dividend of Fagron in the year 2023?
In the year 2023, Fagron distributed 0.2 EUR as dividends.
In which currency does Fagron pay out the dividend?
The dividends of Fagron are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Fagron
Our stock analysis for Fagron Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fagron Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.